Tectonic Therapeutic director Timothy Springer buys $39.9 million in stock
Timothy A. Springer, a director and ten percent owner of Tectonic Therapeutic, Inc. (NASDAQ:TECX), has significantly increased his stake in the company through recent stock purchases. According to a ...
Piper Sandler Reaffirms Their Buy Rating on Tectonic Therapeutic (TECX)
In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Tectonic Therapeutic (TECX – Research Report), with a ...
Truist maintains Eli Lilly stock Buy rating, $1038 target
Truist Securities reaffirmed its Buy rating and $1,038.00 price target for Eli Lilly and Company (NYSE:LLY) shares, with analyst targets ranging from $580 to $1,190. The company, which has ...
Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data
Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...